DexCom, Inc. DXCM

86.62 (0.85) (0.97%) as of 25 Sep
Market cap
$33.0B
P/E
33.4×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

DexCom, Inc. (DXCM) P/B ratio

As of 25 September 2026, DexCom, Inc. (DXCM) trades at a P/B ratio of 12.6×. Over the past ten years it has ranged from 7.5× (April 2026) to 47.5× (September 2015); the current reading is higher than 14% of that period. That is above the Medical Devices industry median of 2.5× and above the Healthcare sector median of 2.5×.

P/B ratio, daily

Annual

Period P/B ratio Change
FY2025 9.4× (35.22%)
FY2024 14.6× (36.62%)
FY2023 23.0× 9.60%
FY2022 21.0× (17.60%)
FY2021 25.4× 33.14%
FY2020 19.1× (15.40%)
FY2019 22.6× 41.74%
FY2018 15.9× 33.48%
FY2017 11.9× (30.43%)
FY2016 17.2× (41.95%)

Quarterly

Period P/B ratio Change
Jun 2026 9.8× 20.06%
Mar 2026 8.2× (13.28%)
Dec 2025 9.4× (2.31%)
Sep 2025 9.7× (27.42%)
42 more quarters

Against its own ten years

Low 7.5× High 47.5×
Ten-year median 20.4×
Current reading's percentile 14

P/B ratio against peers

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on DXCM